PharmaBoardroom’s latest report, InFigures: Asia Pacific 2021 features up-to-date datasets from the region’s leading pharma markets and regional innovation hubs.
Covering everything from population health to market growth, company rankings, innovation footprints, IPOs, and drug approvals, as well as market-specific executive insight from the PharmaBoardroom archives, this exclusive new report is an excellent jumping-off point for those looking to learn more about the world’s most dynamic region.
Featured markets include Asia-Pacific’s largest of PR China, Japan, South Korea, and Australia, as well as smaller but incredibly important innovation, financial, and logistical hubs such as Taiwan, Singapore, and Hong Kong.